Flow Engineering
Seed Round in 2022
Flow Engineering is an innovative company that has developed the first engineering data platform specifically designed for agile engineering teams. The platform streamlines the engineering design process by automating much of the manual execution work, thereby enhancing efficiency and accelerating hardware invention. It facilitates seamless integration of essential data across various tools, allowing engineers to easily develop and iterate complex designs. By building critical software infrastructure, Flow Engineering aims to reinvent traditional engineering frameworks, enabling teams to work more effectively and adapt to changing project requirements.
Running Tide
Series B in 2022
Running Tide crafts adaptive aquaculture techniques to optimize nature while amplifying flavor and health. It applies the minds of scientists to produce exceptionally healthy low-carbon protein. Running Tide analyzes ocean data to determine how to better utilize two-thirds of the Earth’s surface in the climate fight.
HelixNano
Convertible Note in 2020
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re already testing COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
HelixNano
Convertible Note in 2019
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re already testing COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
Glue Collaboration
Seed Round in 2019
In 2004, Santtu Parikka founded Fake Production, a VR and gaming studio that won multiple awards for animation. In recent years, as their passion for all things VR/AR has grown, they’ve been drawn to an important challenge: to enable people thousands of miles apart to collaborate effectively in virtual environments, just as they might in a real physical setting. In 2016, Santtu and their CTO Juha Ruistola revealed the first multi-user VR prototypes. These proved an instant hit. A year later, as they crystallized their new mission, vision and strategy, Glue was born. Since then, their 30-strong team has continued to build on their legacy and break new ground in multi-user VR software, developing Glue into the fully-featured virtual collaboration platform they are today.
HelixNano
Convertible Note in 2017
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re already testing COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.